Benzathine benzylpenicillin


Concise Prescribing Info
Indications/Uses
Listed in Dosage.
Dosage/Direction for Use
Adult : IM Streptococcal pharyngitis; Primary prophylaxis of rheumatic fever 900 mg as a single dose. Prevention of recurrence of acute rheumatic fever 900 mg once every 3 or 4 wk or 450 mg once every 2 wk. Syphilis Primary, secondary, latent: 1.8 g as a single dose. Late (tertiary and neurosyphilis): 1.8 g once wkly for 3 doses. Treponemal infections 900 mg as a single dose.
Dosage Details
Intramuscular
Syphilis
Adult: Primary, secondary and latent: 1.8 g (2.4 MIU) as a single dose. Late (tertiary and neurosyphilis): 1.8 g (2.4 MIU) once wkly for 3 doses.

Intramuscular
Streptococcal pharyngitis
Adult: 900 mg (1.2 MIU) as a single dose.
Child: <27 kg: 225-450 mg (300,000-600,000 U) as a single dose; ≥27 kg: 675 mg (900,000 U) as a single dose.

Intramuscular
Treponemal infections
Adult: 900 mg (1.2 MIU) as a single dose.
Child: 450 mg (600,000 U) as a single dose.

Intramuscular
Congenital syphilis
Child: Normal CSF: <2 yr 37.5 mg/kg (50,000 U/kg) as a single dose; 2-12 yr Adjust dosage based on adult dosage schedule.

Intramuscular
Primary prophylaxis of rheumatic fever
Adult: 900 mg (1.2 MIU) as a single dose. Prevention of recurrence of acute attack: 900 mg (1.2 MIU) once every 3 or 4 wk or 450 mg (600,000 U) once every 2 wk.
Child: <27 kg: 225-450 mg (300,000-600,000 U) as a single dose; ≥27 kg: 675 mg (900,000 U) as a single dose. Prevention of recurrence of acute attack: <27 kg: 450 mg (600,000 U) once every 3 or 4 wk; ≥27 kg: 900 mg (1.2 MIU) once every 3 or 4 wk.
Contraindications
Hypersensitivity to penicillins.
Special Precautions
Patient w/ previous hypersensitivity reactions to cephalosporins, history of allergy, asthma, seizure disorder. Not intended for IV or intra-arterial admin or inj near major peripheral nerves of blood vessels. Prolonged use may result in bacterial or fungal superinfection. Renal impairment.
Adverse Reactions
Hypersensitivity reactions including skin eruptions, urticaria, laryngeal oedema, serum sickness-like reactions, allergic vasculitis, pruritus, fatigue, asthenia, pain, headache; fever; haemolytic anaemia, leucopenia, thrombocytopenia; neuropathy; nephropathy; hypotension, tachycardia, palpitations, pulmonary HTN, pulmonary embolism, vasodilation, vasovagal reaction, cerebrovascular accident, syncope; nausea, vomiting, intestinal necrosis, blood in stool, intestinal necrosis; lymphadenopathy; inj site reactions (e.g. pain, inflammation), joint disorder, periostitis, exacerbation of arthritis, myoglobinuria, rhabdomyolysis; nervousness, tremors, dizziness, somnolence, confusion, anxiety, euphoria, transverse myelitis, seizures, coma; hypoxia, apnoea, dyspnoea; diaphoresis; blurred vision, blindness; neurogenic bladder, haematuria, proteinuria, renal failure, impotence, priapism.
Potentially Fatal: Anaphylaxis, antibiotic-associated pseudomembranous colitis.
MonitoringParameters
Periodic evaluation of renal and haematopoietic functions. Assess culture and sensitivity test prior to initiation of therapy. Monitor for hypersensitivity reactions and opportunistic infections.
Drug Interactions
Bactericidal effect may be antagonised by tetracycline. Decreased rate of excretion and increased serum concentration when used w/ probenecid.
Lab Interference
May cause false-positive result in urinary and/or serum protein test, false positive or negative result for glycosuria test using copper sulfate reagent method, positive Coombs’ test.
Action
Description: Benzathine benzylpenicillin interferes w/ bacterial cell wall synthesis during active multiplication causing cell wall death and resultant bactericidal activity against susceptible bacteria.
Duration: 1-4 wk.
Pharmacokinetics:
Absorption: Slowly absorbed from the site of inj. Time to peak plasma concentration: W/in 12-24 hr.
Distribution: Distributed throughout body tissues; CSF (minimal amount). Plasma protein binding: Approx 60%.
Metabolism: Hydrolysed to benzylpenicillin.
Excretion: Via urine.
Chemical Structure

Chemical Structure Image
Benzathine benzylpenicillin

Source: National Center for Biotechnology Information. PubChem Database. Benzathine benzylpenicillin, CID=15232, https://pubchem.ncbi.nlm.nih.gov/compound/Benzathine-benzylpenicillin (accessed on Jan. 21, 2020)

Storage
Store between 2-8°C. Do not freeze.
MIMS Class
ATC Classification
J01CE08 - benzathine benzylpenicillin ; Belongs to the class of beta-lactamase sensitive penicillins. Used in the systemic treatment of infections.
References
Anon. Penicillin G Benzathine. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 05/09/2016.

Bicillin L-A Injection (Pfizer Laboratories Div Pfizer Inc). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 05/09/2016.

Buckingham R (ed). Benzathine Benzylpenicillin. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 05/09/2016.

McEvoy GK, Snow EK, Miller J et al (eds). Penicillin G Benzathine. AHFS Drug Information (AHFS DI) [online]. American Society of Health-System Pharmacists (ASHP). https://www.medicinescomplete.com. Accessed 05/09/2016.

Pfizer New Zealand Ltd. Bicillin L-A Injection data sheet 8 June 2012. Medsafe. http://www.medsafe.govt.nz/. Accessed 05/09/2016.

Disclaimer: This information is independently developed by MIMS based on Benzathine benzylpenicillin from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2020 MIMS. All rights reserved. Powered by MIMS.com
  • Retarpen
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in